Experienced in Xeroderma Pigmentosum

Dr. Lawrence F. Eichenfield

San Diego, CA
Experienced
in Xeroderma Pigmentosum
Specialties:Dermatology | Pediatrics
OverviewInsuranceLocationsClinical Research

Overview

Lawrence Eichenfield is a Dermatologist and a Pediatrics provider in San Diego, California. Dr. Eichenfield and is rated as an Experienced provider by MediFind in the treatment of Xeroderma Pigmentosum. His top areas of expertise are Atopic Dermatitis, Molluscum Contagiosum, Acne, Gastrostomy, and Tissue Biopsy.

His clinical research consists of co-authoring 349 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Xeroderma Pigmentosum.

Specialties
Dermatology
Pediatrics
Licenses
Dermatology in CA
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

8010 Frost St, Suite 602, San Diego, CA 92123
858-966-6795
Other Locations
3030 Childrens Way, San Diego, CA 92123
858-966-6795

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Combination product
Study Phase: Phase 3
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Enrollment Status: Completed
Publish Date: August 21, 2020
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Enrollment Status: Completed
Publish Date: November 06, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

351 Total Publications

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: January 10, 2025
Similar Doctors
Expertise in
0
conditions
Dr. Bari B. Cunningham
Dermatology
Expertise in
0
conditions
Dr. Bari B. Cunningham
Dermatology

Comprehensive Dermatology Group

781 Garden View Ct, Suite 201, 
Encinitas, CA 
 (19.0 mi)
760-634-3376
Languages Spoken:
English
See accepted insurances

Bari Cunningham is a Dermatologist in Encinitas, California. Dr. Cunningham and is rated as an Experienced provider by MediFind in the treatment of Xeroderma Pigmentosum. Her top areas of expertise are Xeroderma Pigmentosum, Multiple Familial Trichoepithelioma, and Trichoepithelioma.

Expertise in
3
conditions
Dr. Austin B. Ambur
Dermatology
Expertise in
3
conditions
Dr. Austin B. Ambur
Dermatology

Grossmont Dermatology Medical Clinic

8860 Ctr Dr, Suite 300, 
La Mesa, CA 
 (8.5 mi)
619-462-1670
Languages Spoken:
English

Austin Ambur is a Dermatologist in La Mesa, California. Dr. Ambur and is rated as an Advanced provider by MediFind in the treatment of Xeroderma Pigmentosum. His top areas of expertise are Muir-Torre Syndrome, Bullae, DRESS Syndrome, and Graham-Little-Piccardi-Lassueur Syndrome.

Expertise in
68
conditions
Dr. Antoanella Calame
Dermatology
Expertise in
68
conditions
Dr. Antoanella Calame
Dermatology

Compass Dermatopathology Inc

6605 Nancy Ridge Dr, 
San Diego, CA 
 (6.1 mi)
858-750-2983
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Antoanella Calame is a Dermatologist in San Diego, California. Dr. Calame and is rated as a Distinguished provider by MediFind in the treatment of Xeroderma Pigmentosum. Her top areas of expertise are Seborrheic Keratosis, Warts, Basal Cell Skin Cancer, Syringocystadenoma Papilliferum, and Tissue Biopsy. Dr. Calame is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile